Last reviewed · How we verify
Flomax
At a glance
| Generic name | Flomax |
|---|---|
| Also known as | Tamsulosin |
| Sponsor | Emory University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- : Efficacy of Silodosin Versus Tamsulosin in Patients With Moderate to Severe Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Randomized Crossover Clinical Trial (Phase 4)
- Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure (NA)
- An Open-label, Randomized, Single Dose, Two-Period Crossover Study to Determine the Bioavailability of a Fixed Dose Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5mg/0 (Phase 1)
- An Open-label, Randomized, Single Dose, Two-way Crossover Study to Determine the Bioavailability of One Fixed Dose Combination Capsule Formulation of Dutasteride and Tamsulosin Hydrochloride (0.5 mg/0 (Phase 1)
- Prostate Medication, Metabolism and Gut Microbiota (Phase 4)
- Decreasing Rates of Intraurethral Catheterization Postoperatively in Spine Surgery (Phase 4)
- Pre-operative Tamsulosin After Minimally Invasive Hysterectomy and Time to Spontaneous Void: A Randomized Controlled Trial (Phase 2)
- A Prospective Randomized Trial "The Effectiveness of Peripheral Magnetic Stimulation in Men With Lower Urinary Tract Symptoms" (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Flomax CI brief — competitive landscape report
- Flomax updates RSS · CI watch RSS
- Emory University portfolio CI